Linden Thomas Advisory Services LLC Purchases 2,253 Shares of Encompass Health Co. (NYSE:EHC)

Posted by Defense World Staff on Jul 11th, 2023

Linden Thomas Advisory Services LLC boosted its position in Encompass Health Co. (NYSE:EHC – Free Report) by 23.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,924 shares of the company’s stock after acquiring an additional 2,253 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in Encompass Health were worth $645,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. California Public Employees Retirement System grew its stake in shares of Encompass Health by 3.9% during the fourth quarter. California Public Employees Retirement System now owns 241,527 shares of the company’s stock valued at $14,446,000 after buying an additional 9,173 shares during the last quarter. Trilogy Capital Inc. boosted its holdings in shares of Encompass Health by 9.0% during the first quarter. Trilogy Capital Inc. now owns 5,508 shares of the company’s stock worth $298,000 after purchasing an additional 453 shares during the period. Teacher Retirement System of Texas boosted its holdings in shares of Encompass Health by 17.2% during the fourth quarter. Teacher Retirement System of Texas now owns 37,729 shares of the company’s stock worth $2,257,000 after purchasing an additional 5,546 shares during the period. First Trust Advisors LP boosted its holdings in shares of Encompass Health by 10.9% during the fourth quarter. First Trust Advisors LP now owns 552,707 shares of the company’s stock worth $33,057,000 after purchasing an additional 54,103 shares during the period. Finally, Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Encompass Health by 66.9% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 8,279 shares of the company’s stock worth $495,000 after purchasing an additional 3,319 shares during the period. 92.78% of the stock is owned by institutional investors.

Encompass Health Price Performance

Shares of NYSE EHC opened at $66.54 on Tuesday. Encompass Health Co. has a fifty-two week low of $45.11 and a fifty-two week high of $67.90. The company has a 50 day simple moving average of $63.43 and a two-hundred day simple moving average of $60.70. The company has a market capitalization of $6.67 billion, a price-to-earnings ratio of 24.64, a P/E/G ratio of 1.76 and a beta of 1.07. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.29 and a current ratio of 1.29.

Encompass Health (NYSE:EHC – Get Free Report) last announced its earnings results on Friday, April 28th. The company reported $0.88 earnings per share for the quarter, beating analysts’ consensus estimates of $0.70 by $0.18. The business had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.14 billion. Encompass Health had a net margin of 5.75% and a return on equity of 16.80%. The business’s revenue for the quarter was down 13.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.97 earnings per share. Analysts expect that Encompass Health Co. will post 3.19 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, July 17th. Investors of record on Monday, July 3rd will be given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.90%. The ex-dividend date is Friday, June 30th. Encompass Health’s dividend payout ratio (DPR) is currently 22.22%.

Analyst Ratings Changes

A number of analysts have recently weighed in on EHC shares. Bank of America increased their target price on shares of Encompass Health from $69.00 to $74.00 in a report on Friday, April 28th. Stephens increased their target price on shares of Encompass Health from $74.00 to $78.00 in a report on Thursday, June 29th. Barclays raised their price objective on shares of Encompass Health from $57.00 to $61.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 4th. StockNews.com began coverage on shares of Encompass Health in a report on Thursday, May 18th. They issued a “buy” rating for the company. Finally, Mizuho raised their price objective on shares of Encompass Health from $69.00 to $74.00 in a report on Monday, May 1st. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Encompass Health currently has an average rating of “Buy” and an average target price of $71.64.

About Encompass Health

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.